Search results for "Caliciviridae Infection"

showing 10 items of 62 documents

Molecular Epidemiology of Caliciviruses Causing Outbreaks and Sporadic Cases of Acute Gastroenteritis in Spain

2002

ABSTRACT The molecular epidemiology of human caliciviruses (HuCVs) causing sporadic cases and outbreaks of acute gastroenteritis around eastern Spain (Catalonia and the Valencian Community) was studied by reverse transcription-PCR (RT-PCR) and by sequencing part of the RNA polymerase gene in open reading frame 1. HuCVs were detected in 44 of 310 stool specimens (14.19%) negative for other enteric pathogens obtained from children with acute gastroenteritis. Norwalk-like viruses (NLVs) were the most common cause of the gastroenteritis outbreaks investigated here. They were detected in 14 out of 25 (56%) outbreaks with an identified pathogen. Genotypes producing both sporadic cases and outbrea…

Microbiology (medical)virusesMolecular Sequence DataBiologySapovirusVirusDisease Outbreakslaw.inventionlawVirologyGenotypeHumansPathogenGenePhylogenyPolymerase chain reactionFecesCaliciviridae InfectionsMolecular EpidemiologyMolecular epidemiologyReverse Transcriptase Polymerase Chain ReactionNorovirusOutbreakDNA-Directed RNA PolymerasesSequence Analysis DNAVirologyGastroenteritisSpainChild PreschoolAcute DiseaseCaliciviridaeJournal of Clinical Microbiology
researchProduct

Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsi…

1996

Two myxoma virus-rabbit hemorrhagic disease virus (RHDV) recombinant viruses were constructed with the SG33 strain of myxoma virus to protect rabbits against myxomatosis and rabbit viral hemorrhagic disease. These recombinant viruses expressed the RHDV capsid protein (VP60). The recombinant protein, which is 60 kDa in size, was antigenic, as revealed by its reaction in immunoprecipitation with antibodies raised against RHDV. Both recombinant viruses induced high levels of RHDV- and myxoma virus-specific antibodies in rabbits after immunization. Inoculations by the intradermal route protected animals against virulent RHDV and myxoma virus challenges.

RNA virusesHemorrhagic Disease Virus Rabbitanimal diseasesvirusesLeporipoxviruslaw.invention0403 veterinary sciencelawVIRUS RECOMBINEComputingMilieux_MISCELLANEOUSCaliciviridae Infections[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology0303 health sciencesVaccines SyntheticMyxomatosisLagovirus04 agricultural and veterinary sciences3. Good healthLagovirusCapsid[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyRecombinant DNAcardiovascular systemRabbitsReassortant VirusesLeporipoxvirusResearch Article040301 veterinary sciencesImmunologyDNA RecombinantMyxoma virusBiologyMicrobiologyVirus03 medical and health sciencesMyxomatosis InfectiousImmunity reactionsVirologyReassortant VirusesmedicineAnimalsRabbit diseasesRecombinant vaccinescardiovascular diseasesImmune response030304 developmental biologyViral Structural ProteinsViral infectionsMyxoma virusbiology.organism_classificationmedicine.diseaseVirologyMédecine vétérinaire et santé animalInsect ScienceExperimental infectionsDNA ViralDNA virusesJournal of virology
researchProduct

Risk factors for gastroenteritis associated with canal swimming in two cities in the Netherlands during the summer of 2015: A prospective study

2017

Urban canal swimming events are popular in the Netherlands. In 2015, two city canal swimming events took place, in Utrecht (Utrecht Singel Swim, USS) and in Amsterdam (Amsterdam City Swim, ACS). This prospective study characterizes the health risks associated with swimming in urban waters. Online questionnaires were sent to 160 (USS) and 2,692 (ACS) participants, with relatives of participants who did not swim completing the questionnaire as a control. Swimming water specimens and stool specimens of diarrheic participants in the ACS group were analysed. A total of 49% of USS and 51% of ACS swimmers returned their questionnaires. Nine percent of USS swimmers and 4% of non-swimmers reported g…

RNA virusesQuestionnaires0301 basic medicineMalePediatricsPhysiologyWater contaminationlcsh:MedicineFresh WaterPathology and Laboratory Medicinemedicine.disease_causeDisease OutbreaksFecesRisk FactorsSurveys and QuestionnairesWater QualityEpidemiologyMedicine and Health SciencesProspective StudiesProspective cohort studylcsh:ScienceCaliciviridae InfectionsNetherlandsMultidisciplinarySewageEnterobacteriaceae InfectionsMiddle AgedBacterial PathogensGastroenteritisMedical MicrobiologyResearch DesignViral PathogensVirusesEngineering and TechnologyFemalePathogensAnatomyWater MicrobiologyResearch ArticleAdultmedicine.medical_specialtyEnvironmental EngineeringAdolescent030106 microbiologyResearch and Analysis MethodsMicrobiologyCaliciviruses03 medical and health sciencesYoung AdultEnterobacteriaceaeSurface WaterEnvironmental healthmedicineHumansMicrobial PathogensSwimmingSurvey ResearchBacteriaBiological Locomotionbusiness.industryNorovirusWater Pollutionlcsh:ROrganismsBiology and Life SciencesOutbreakGastrointestinal TractEarth SciencesNoroviruslcsh:QHydrologybusinessDigestive SystemEnterococcus
researchProduct

Evaluation of silver-infused polylactide films for inactivation of Salmonella and feline calicivirus in vitro and on fresh-cut vegetables

2012

There is a growing trend to develop packaging materials with an active role in guarantying that the quality and safety characteristics of packaged products will remain or improve from preparation throughout shelf-life. In the present study, 0.001-1.0 wt.% silver ions were satisfactorily incorporated into polylactide (PLA) films by a solvent casting technique. Silver migration from the films was measured by voltamperometry and then correlated with its antimicrobial efficacy against Salmonella enterica and feline calicivirus (FCV), a human norovirus surrogate, by using the Japanese industrial standard (JIS Z 2801). The PLA-silver films showed strong antibacterial and antiviral activity in vit…

SalmonellaSilverPolyestersActive packagingmedicine.disease_causeMicrobiologyMicrobiologyAnti-Infective AgentsSalmonellaVegetablesProduct PackagingmedicineCaliciviridae InfectionsInfectivityFeline calicivirusbiologyChemistryTemperatureCalicivirusSilver CompoundsGeneral MedicineLettucebiology.organism_classificationAntimicrobialSalmonella entericaVirus InactivationAntibacterial activityCalicivirus FelineFood ScienceInternational Journal of Food Microbiology
researchProduct

Seroprevalence of Norovirus Genogroup IV Antibodies among Humans, Italy, 2010–2011

2014

Antibodies specific to genogroup IV identified in human specimens suggest zoonotic exposure.

Settore MED/07 - Microbiologia E Microbiologia ClinicaEpidemiologyviruseslcsh:MedicineAntibodies Viralmedicine.disease_causeImmunoglobulin Gfluids and secretionsSeroepidemiologic StudiesGenotypeantibodiesChildCaliciviridae InfectionsAged 80 and overeducation.field_of_studybiologyTransmission (medicine)genogroupsvirus diseasesMiddle AgedGastroenteritisInfectious DiseasesItalyChild PreschoolnorovirusesAdultMicrobiology (medical)carnivoresSeroprevalence of Norovirus Genogroup IV Antibodies among Humans Italy 2010–2011AdolescentGenotypePopulationGIV NoVsinterspecies transmissionGenogroup IVHistory 21st Centurylcsh:Infectious and parasitic diseasesYoung AdultAge Distributionstomatognathic systemmedicineHumansSeroprevalencelcsh:RC109-216educationAgedNoroviruResearchNoroviruslcsh:RInfant NewbornInfantSeroepidemiologic StudiesVirologydigestive system diseaseszoonosesNoVsCaliciviridae InfectionsImmunoglobulin Gbiology.proteinNorovirusEmerging Infectious Diseases
researchProduct

Identification of the novel Kawasaki 2014 GII.17 human norovirus strain in Italy, 2015

2015

Surveillance of noroviruses in Italy identified the novel GII.17 human norovirus strain, Kawasaki 2014, in February 2015. This novel strain emerged as a major cause of gastroenteritis in Asia during 2014/15, replacing the pandemic GII.4 norovirus strain Sydney 2012, but being reported only sporadically elsewhere. This novel strain is undergoing fast diversification and continuous monitoring is important to understand the evolution of noroviruses and to implement the future strategies on norovirus vaccines.

Settore MED/07 - Microbiologia E Microbiologia ClinicaGenotypeEpidemiologyvirusesBiologymedicine.disease_causeCommunicable Diseases EmergingMicrobiologyDisease OutbreaksEpidemiology; Public Health Environmental and Occupational Health; Virologyfluids and secretionsVirologyPandemicmedicineHumansPhylogenyCaliciviridae InfectionsMolecular EpidemiologyMolecular epidemiologyStrain (biology)NorovirusPublic Health Environmental and Occupational Healthvirus diseasesGenetic VariationDNA-Directed RNA PolymerasesVirologydigestive system diseasesGastroenteritisCaliciviridae InfectionsItalyPopulation SurveillanceNorovirusFemaleSeasonsSequence Analysis
researchProduct

Epidemiological dynamics of norovirus GII.4 variant New Orleans 2009.

2015

Norovirus (NoV) is one of the major causes of diarrhoeal disease with epidemic, outbreak and sporadic patterns in humans of all ages worldwide. NoVs of genotype GII.4 cause nearly 80–90 % of all NoV infections in humans. Periodically, some GII.4 strains become predominant, generating major pandemic variants. Retrospective analysis of the GII.4 NoV strains detected in Italy between 2007 and 2013 indicated that the pandemic variant New Orleans 2009 emerged in Italy in the late 2009, became predominant in 2010–2011 and continued to circulate in a sporadic fashion until April 2013. Upon phylogenetic analysis based on the small diagnostic regions A and C, the late New Orleans 2009 NoVs circulati…

Settore MED/07 - Microbiologia E Microbiologia ClinicaGenotypeMolecular Sequence DataBiologymedicine.disease_causeGenomeFecesOpen Reading FramesPhylogeneticsVirologyPandemicGenotypemedicineHumansAmino Acid SequencePhylogenyCaliciviridae InfectionsRetrospective StudiesGeneticsnorovirus GII.4 variant New Orleans 2009 epidemiologyPhylogenetic treeNorovirusOutbreakNew OrleansVirologyGastroenteritisCaliciviridae InfectionsItalyNorovirusCapsid ProteinsSequence AlignmentThe Journal of general virology
researchProduct

Genotyping of GII.4 and GIIb norovirus RT-PCR amplicons by RFLP analysis

2007

GII.4 and GIIb/Hilversum norovirus (NoV) strains appear to have a prominent epidemiological role in outbreaks or sporadic cases of human gastroenteritis. Sequence analysis, although laborious, is the reference method used for characterization of noroviruses. In this study a screening test is proposed to characterize GIIb and GII.4 NoVs based on restriction fragment length polymorphism (RFLP) analysis of amplicons obtained from the RNA-dependent RNA polymerase (RdRp) region. Virtual analysis of 793 RdRp sequences of GGI and GGII NoVs, retrieved from GenBank, and representative of global geographical origins on a long-time period, permitted the selection of four restriction enzymes, XmnI, Ahd…

Settore MED/07 - Microbiologia E Microbiologia ClinicaGenotypeSequence analysisvirusesBiologymedicine.disease_causeVirologyGenotypemedicineHumansTypingGenotypingCaliciviridae InfectionsGeneticsReverse Transcriptase Polymerase Chain ReactionNorovirusvirus diseasesInfantVirologyGastroenteritisRestriction enzymeGIIb/Hilversum strain GII.4 genotype Restriction fragment length polymorphism (RFLP)GenBankChild PreschoolNorovirusRNA ViralRestriction fragment length polymorphismPolymorphism Restriction Fragment Length
researchProduct

Detection of the norovirus variants GGII.4 hunter and GGIIb/hilversum in Italian children with gastroenteritis.

2006

Noroviruses (NoVs) are important enteric pathogens of humans. Although they exhibit an impressive genetic diversity, few NoV strains appear to predominate worldwide. Limited epidemiological data are available on NoV gastroenteritis in Italy. In this study, we assessed the prevalence of human NoV in Italian children with gastroenteritis by using a reverse-transcription nested polymerase chain reaction (RT-PCR) assay specific for the RNA-dependent RNA polymerase (RdRp) on faecal samples collected throughout the 2004 surveillance activity in Palermo, Italy. NoVs were detected in 47% of the stool samples obtained from children <5 years age, admitted to hospital with acute non-bacterial gastroen…

Settore MED/07 - Microbiologia E Microbiologia ClinicaSettore MED/17 - Malattie InfettiveBiologymedicine.disease_causeVirusEnteritisFecesVirologyGenotypemedicineHumansTypingGenotypingPhylogenyCaliciviridae InfectionsMolecular EpidemiologyMolecular epidemiologyReverse Transcriptase Polymerase Chain ReactionNorovirusGenetic VariationInfantSequence Analysis DNANorovirus gastroenteritismedicine.diseaseRNA-Dependent RNA PolymeraseVirologyGastroenteritisInfectious DiseasesItalyNorovirusRNA ViralNested polymerase chain reactionJournal of medical virology
researchProduct

Quasispecies dynamics and molecular evolution of human norovirus capsid P region during chronic infection.

2009

In this novel study, we have for the first time identified evolutionarily conserved capsid residues in an individual chronically infected with norovirus (GGII.3). From 2000 to 2003, a total of 147 P1-1 and P2 capsid sequences were sequenced and investigated for evolutionarily conserved and functionally important residues by the evolutionary trace (ET) algorithm. The ET algorithm revealed more absolutely conserved residues (ACR) in the P1-1 domain (47/53, 88 %) as compared with the P2 domain (86/133, 64 %). The capsid P1-1 and P2 domains evolved in time-dependent manner, with a distinct break point observed between autumn/winter of year 2000 (isolates P1, P3 and P5) and spring to autumn of y…

Trisaccharide bindingMolecular Sequence DataViral quasispeciesBiologymedicine.disease_causeEvolution MolecularFecesMolecular evolutionVirologymedicineHumansAmino Acid SequenceCloning MolecularReceptorConserved SequencePhylogenyCaliciviridae InfectionsDNA PrimersImmunosuppression TherapyBinding SitesStrain (chemistry)Reverse Transcriptase Polymerase Chain ReactionNorovirusVirologyChronic infectionCapsidNorovirusBlood Group AntigensRNA ViralCapsid ProteinsSeasonsAlgorithmsThe Journal of general virology
researchProduct